The Health Technology Assessment (HTA) unit held its first public consultation last June 11, 2020 through Zoom Teleconference to present the initial results of the reassessment of Pneumococcal Conjugate Vaccines (PCV) which is currently implemented by the DOH- National Immunization Program (NIP). True to the mandate of HTA to be a fair and transparent prioritization continue reading : DOH Holds First HTA Public Consultation
Rapid Review (2020): Favipiravir for treatment of COVID-19
Return to Latest Recommendation Date of publication: April 8, 2020
Meglumine Acridone Acetate (Cycloferon)
MEGLUMINE ACRIDONE ACETATE (CYCLOFERON) FOR COVID-19 Date of publication: April 7, 2020 Objectives: Evidence summary: Meglumine acridone acetate Rapid review: Use of Meglumine acridone acetate (MA) for treating patients with COVID-19